(E)-Methyl 3-(3,5-difluoro-4-formylphenyl)acrylate, 97.0%, 250mg

o-Acetoacetanisidide>98.0%(HPLC)(N)500g

N-Methyl-3-(trifluoromethyl)cyclobutanamine hydrochloride, 98%, 250mg

(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 98%, 25mg

[1,1'-Biphenyl]-3,4'-diyldimethanol, 96%, 100mg

9-(Benzyloxy)-3-(2-hydroxyethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 98%, 100mg

5-(4-(Bis(4-bromophenyl)amino)phenyl)thiophene-2-carbaldehyde, 97%, 100mg

6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3R)-3-piperidinylpyrazolo[1,5-a]pyrimidin-7-amine, 98.0%, 10mg

4-Bromo-6-chloro-3-iodo-2-methylpyridine, 95%, 500mg

(E)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-one, 97%, 1g

4-tert-Butycyclohexanecarboxylic acid, 95.0%, 5g

1,4-Dimethoxy-2-vinylbenzene, 95%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-4-(3-cyanophenyl)butanoic acid, 97%, 1g